# Long-Acting Tacrolimus for the Treatment of Resistant Lupus Nephritis

> **NCT01206569** · PHASE4 · COMPLETED · sponsor: **Chinese University of Hong Kong** · enrollment: 2 (actual)

## Conditions studied

- Lupus Nephritis

## Interventions

- **DRUG:** Long-acting tacrolimus (Advagraf, Astellas Pharma)

## Key facts

- **NCT ID:** NCT01206569
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09
- **Primary completion:** 2011-12
- **Final completion:** 2012-02
- **Target enrollment:** 2 (ACTUAL)
- **Last updated:** 2012-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01206569

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01206569, "Long-Acting Tacrolimus for the Treatment of Resistant Lupus Nephritis". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01206569. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*